Discover

WAT
Waters Corporation
304.24
200 x 298.37
80 x 305.42
bid
ask
+
4.35
1.45%
140 @ 04:00 PM
304.24 +0.00 (0.00%)
Ytd -19.90%
1y -16.10%
294.21
day range
306.54
277.72
52 week range
412.54
Open 295.37 Prev Close 299.89 Low 294.21 High 306.54 Mkt Cap 29.85B
Vol 574.39K Avg Vol 1.10M EPS 10.77 P/E 28.25 Forward P/E 18.61
Beta 1.20 Short Ratio 1.92 Inst. Own 60.90% Dividend N/A Div Yield N/A
Ex Div Date 11-26 Earning 05-05 50-d Avg 327.21 200-d Avg 337.27 1yr Est 393.14
Earning
Date For Estimate Reported Surprise surprise %
2026-05-05 2026-03 2.3 N/A N/A N/A
2026-02-09 2025-12 4.5 4.53 0.03 0.67%
2025-11-04 2025-09 3.21 3.4 0.19 5.92%
2025-08-04 2025-06 2.93 2.95 0.02 0.68%
2025-05-06 2025-03 2.22 2.25 0.03 1.35%
2025-02-12 2024-12 4.02 4.1 0.08 1.99%
Upgrade / Downgrade
Date Firm Action From To
2026-03-25 Deutsche Bank Upgrade Hold Hold
2026-02-23 Morgan Stanley Upgrade Equal-Weight Equal-Weight
2026-02-11 Wells Fargo Upgrade Equal-Weight Equal-Weight
2026-02-10 UBS Upgrade Neutral Neutral
2026-02-10 Guggenheim Upgrade Buy Buy
2026-02-10 B of A Securities Upgrade Neutral Neutral
Profile
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Insider Holder
Date Name Relation Quantity Description
2026-02-24 BATRA UDIT Chief Executive Officer 36.56K Stock Award(Grant)
2026-02-24 BENNETT JIANQING Officer 7.24K Stock Award(Grant)
2026-02-24 CARPIO ROBERT L III Officer 3.62K Stock Award(Grant)
2026-02-24 CHAUBAL AMOL Chief Financial Officer 8.51K Stock Award(Grant)
2026-03-05 FEARON RICHARD H Director 3.30K Purchase
2026-02-24 HUANG PEARL S. Director 3.28K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Vanguard Group Inc 7.47M 2.27B 7.61%
2025-12-30 Blackrock Inc. 5.43M 1.65B 5.54%
2025-12-30 Fundsmith LLP 3.56M 1.08B 3.63%
2025-12-30 State Street Corporation 2.68M 816.32M 2.74%
2025-12-30 Massachusetts Financial Services Co. 2.62M 798.54M 2.68%
2025-12-30 Alliancebernstein L.P. 2.07M 628.83M 2.11%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 1.88M 570.66M 1.91%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 1.50M 456.77M 1.53%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund 1.30M 394.24M 1.32%
2026-02-27 Fidelity Concord Street Trust-Fidelity 500 Index Fund 1.25M 380.71M 1.28%
2025-12-30 JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund 927.20K 282.09M 0.95%
2026-01-30 iShares Trust-iShares Core S&P 500 ETF 765.61K 232.93M 0.78%
Dividend
Dividend Date
0.16 1996-11-26
Split
Split Date
2 : 1 2000-08-28
2 : 1 1999-06-11